74. Prolactin secreting pituitary adenoma Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 19 / Drugs : 28 - (DrugBank : 10) / Drug target genes : 14 - Drug target pathways : 65
Prolactin secreting pituitary adenoma and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 74 | Prolactin secreting pituitary adenoma |
| 75 | Cushing disease |
| 299 | Cystic fibrosis |
| 2 | Amyotrophic lateral sclerosis |
| 86 | Pulmonary arterial hypertension |
| 7 | Corticobasal degeneration |
| 6 | Parkinson disease |
| 164 | Oculocutaneous albinism |
| 67 | Polycystic kidney disease |
| 78 | Hypopituitarism |
| 90 | Retinitis pigmentosa |
| 4 | Primary lateral sclerosis |
| 309 | Progressive myoclonus epilepsy |
| 201 | Angelman syndrome |
| 140 | Dorabe syndrome |
| 17 | Multiple system atrophy |
| 83 | Addison disease |
| 76 | Pituitary gonadotropin secretion hyperthyroidism |
| 46 | Malignant rheumatoid arthritis |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 187 | Kabuki syndrome |
| 113 | Muscular dystrophy |
| 65 | Primary immunodeficiency |
| 51 | Scleroderma |
| 96 | Crohn disease |
| 191 | Werner syndrome |
| 220 | Rapidly progressive glomerulonephritis |
| 30 | Distal myopathy |